Intel (INTC) 10-K risk factor changes: FY2025 vs FY2024

| | | | Liquidity and capital resources | | | Pages [removed: [28](#i52fa34b6ba9248c7a0a794e31846504f_157)\-[30](#i52fa34b6ba9248c7a0a794e31846504f_169), [30](#i52fa34b6ba9248c7a0a794e31846504f_15393162793225)] [added: [29](#i0ab1c04f4cd944ffa1b64a7738970255_133)\-[32](#i0ab1c04f4cd944ffa1b64a7738970255_133)] | | |

| | | | Results of operations | | | Pages [removed: [13](#i52fa34b6ba9248c7a0a794e31846504f_70)\-[27](#i52fa34b6ba9248c7a0a794e31846504f_154)] [added: [18](#i0ab1c04f4cd944ffa1b64a7738970255_73)\-[29](#i0ab1c04f4cd944ffa1b64a7738970255_130)] | | |

| Item 7A. | | | Quantitative and Qualitative Disclosures About Market Risk | | | Pages [removed: [47](#i52fa34b6ba9248c7a0a794e31846504f_199)\-[48](#i52fa34b6ba9248c7a0a794e31846504f_202)] [added: [33](#i0ab1c04f4cd944ffa1b64a7738970255_175)] | | |

| Item 8. | | | Financial Statements and Supplementary Data | | | Pages [removed: [53](#i52fa34b6ba9248c7a0a794e31846504f_229)\-[101](#i52fa34b6ba9248c7a0a794e31846504f_469)] [added: [56](#i0ab1c04f4cd944ffa1b64a7738970255_205)\-[108](#i0ab1c04f4cd944ffa1b64a7738970255_457)] | | |

| | | | Critical accounting estimates | | | Pages [34](#i0ab1c04f4cd944ffa1b64a7738970255_145)\-[36](#i0ab1c04f4cd944ffa1b64a7738970255_145), [65](#i0ab1c04f4cd944ffa1b64a7738970255_244)\-[72](#i0ab1c04f4cd944ffa1b64a7738970255_322) | | |

| | | | Critical accounting estimates | | | Pages [30](#i52fa34b6ba9248c7a0a794e31846504f_169), [62](#i52fa34b6ba9248c7a0a794e31846504f_268)\-[68](#i52fa34b6ba9248c7a0a794e31846504f_346) | | |

| | | | General development of business | | | Pages [removed: [3](#i52fa34b6ba9248c7a0a794e31846504f_25)\-[4](#i52fa34b6ba9248c7a0a794e31846504f_40), [13](#i52fa34b6ba9248c7a0a794e31846504f_70)] [added: [3](#i0ab1c04f4cd944ffa1b64a7738970255_28)\-[5](#i0ab1c04f4cd944ffa1b64a7738970255_43), [18](#i0ab1c04f4cd944ffa1b64a7738970255_73)] | | |

| | | | Available information | | | Page [removed: [2](#i52fa34b6ba9248c7a0a794e31846504f_22)] [added: [2](#i0ab1c04f4cd944ffa1b64a7738970255_22)] | | |

| Item 1A. | | | Risk Factors | | | Pages [removed: [31](#i52fa34b6ba9248c7a0a794e31846504f_193)\-[46](#i52fa34b6ba9248c7a0a794e31846504f_196)] [added: [37](#i0ab1c04f4cd944ffa1b64a7738970255_169)\-[51](#i0ab1c04f4cd944ffa1b64a7738970255_172)] | | |

| | | | Description of business | | | Pages [3](#i0ab1c04f4cd944ffa1b64a7738970255_28)\-[24](#i0ab1c04f4cd944ffa1b64a7738970255_100), [33](#i0ab1c04f4cd944ffa1b64a7738970255_175), [52](#i0ab1c04f4cd944ffa1b64a7738970255_199), [72](#i0ab1c04f4cd944ffa1b64a7738970255_322)\-[75](#i0ab1c04f4cd944ffa1b64a7738970255_322) | | |

| | | | Description of business | | | Pages [3](#i52fa34b6ba9248c7a0a794e31846504f_25)\-[20](#i52fa34b6ba9248c7a0a794e31846504f_124), [45](#i52fa34b6ba9248c7a0a794e31846504f_196)\-[47](#i52fa34b6ba9248c7a0a794e31846504f_199), [51](#i52fa34b6ba9248c7a0a794e31846504f_223), [68](#i52fa34b6ba9248c7a0a794e31846504f_346)\-[72](#i52fa34b6ba9248c7a0a794e31846504f_346) | | |

| | | | For the fiscal year ended December [removed: 28, 2024.] [added: 27, 2025.] | | |

][added: cover.jpg](https://www.sec.gov/Archives/edgar/data/50863/000005086326000011/intc-20251227_g1.jpg)]

The aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of June [removed: 28, 2024,] [added: 27, 2025,] based upon the closing price of the common stock as reported by the Nasdaq Global Select Market on such date, was [removed: $132.4] [added: $99.3] billion.

[removed: 4,330] [added: 4,995] million shares of common stock were outstanding as of January [removed: 24, 2025.][added: 16, 2026.]

Portions of the registrant's proxy statement related to its [removed: 2025] [added: 2026] Annual Stockholders' Meeting to be filed subsequently are incorporated by reference into Part III of this Form 10-K.

The order and presentation of content in our Form 10-K [removed: differs] [added: differ] from the traditional SEC Form 10-K format.

The preparation of our Consolidated Financial Statements is in conformity with [removed: US] [added: U.S.] GAAP.

| [removed: Fundamentals of] Our Business | | | | | | [removed: Page | | |]

| Availability of Company Information | | | | | | [removed: [2](#i52fa34b6ba9248c7a0a794e31846504f_22)] [added: 2] | | |

| [removed: Fundamental of] Our Business | | | | | | [removed: [3](#i52fa34b6ba9248c7a0a794e31846504f_25)] [added: [6](#i0ab1c04f4cd944ffa1b64a7738970255_46)] | | |

| Our Strategy | | | | | | [removed: [3](#i52fa34b6ba9248c7a0a794e31846504f_37)] [added: [3](#i0ab1c04f4cd944ffa1b64a7738970255_40)] | | |

| Operating Segment [removed: Trends and] Results | | | | | | [removed: [14](#i52fa34b6ba9248c7a0a794e31846504f_4142) | | |]

| Consolidated Results of Operations | | | | | | [removed: [23](#i52fa34b6ba9248c7a0a794e31846504f_127)] [added: [25](#i0ab1c04f4cd944ffa1b64a7738970255_103)] | | |

| Liquidity and Capital Resources | | | | | | [removed: [28](#i52fa34b6ba9248c7a0a794e31846504f_157)] [added: [29](#i0ab1c04f4cd944ffa1b64a7738970255_133)] | | |

| Critical Accounting Estimates | | | | | | [removed: [30](#i52fa34b6ba9248c7a0a794e31846504f_169)] [added: [34](#i0ab1c04f4cd944ffa1b64a7738970255_145)] | | |

| [removed: Risk Factors and] Other Key Information | | | | | | | | |

| Risk Factors | | | | | | [removed: [31](#i52fa34b6ba9248c7a0a794e31846504f_193) | | |]

| Quantitative and Qualitative Disclosures About Market Risk | | | | | | [removed: [47](#i52fa34b6ba9248c7a0a794e31846504f_199)] [added: [33](#i0ab1c04f4cd944ffa1b64a7738970255_175)] | | |

| Market for Our Common Stock | | | | | | [removed: [49](#i52fa34b6ba9248c7a0a794e31846504f_211)] [added: [53](#i0ab1c04f4cd944ffa1b64a7738970255_187)] | | |

| Stock Performance Graph | | | | | | [removed: [50](#i52fa34b6ba9248c7a0a794e31846504f_214)] [added: [53](#i0ab1c04f4cd944ffa1b64a7738970255_190)] | | |

| Issuer Purchases of Equity Securities | | | | | | [removed: [50](#i52fa34b6ba9248c7a0a794e31846504f_217)] [added: [53](#i0ab1c04f4cd944ffa1b64a7738970255_193)] | | |

| Rule 10b5-1 Trading Arrangements | | | | | | [removed: [50](#i52fa34b6ba9248c7a0a794e31846504f_220)] [added: [54](#i0ab1c04f4cd944ffa1b64a7738970255_196)] | | |

| Information About Our Executive Officers | | | | | | [removed: [51](#i52fa34b6ba9248c7a0a794e31846504f_223)] [added: [52](#i0ab1c04f4cd944ffa1b64a7738970255_199)] | | |

| Disclosure Pursuant to Section 13(r) of the Securities Exchange Act of 1934 | | | | | | [removed: [52](#i52fa34b6ba9248c7a0a794e31846504f_226)] [added: [54](#i0ab1c04f4cd944ffa1b64a7738970255_202)] | | |

| [added: Notes to] Consolidated Financial Statements | | | | | | [removed: [57](#i52fa34b6ba9248c7a0a794e31846504f_241)] [added: [65](#i0ab1c04f4cd944ffa1b64a7738970255_241)] | | |

| Notes to Consolidated Financial Statements | | | | | | [removed: [62](#i52fa34b6ba9248c7a0a794e31846504f_265)] | | | [added: [65](#i0ab1c04f4cd944ffa1b64a7738970255_238) | | |]

| Form 10-K Cross-Reference Index | | | | | | [removed: [108](#i52fa34b6ba9248c7a0a794e31846504f_490)] [added: [116](#i0ab1c04f4cd944ffa1b64a7738970255_478)] | | |

Words such as "accelerate", "achieve", "aim", "ambitions", "anticipate", "believe", "committed", "continue", "could", "designed", "estimate", "expect", "forecast", "future", "goals", "grow", "guidance", "intend", "likely", "may", "might", "milestones", "next generation", "objective", "on track", "opportunity", "outlook", "pending", "plan", "position", "possible", "potential", "predict", "progress", "ramp", "roadmap", "seek", "should", "strive", "targets", "to be", "upcoming", "will", [removed: "would",] [added: "would"] and variations of such words and similar expressions are intended to identify such forward-looking statements, which may include statements regarding:

▪projections of our future financial performance, including future revenue, gross [removed: margins,] [added: profits,] capital [removed: expenditures, profitability,] [added: expenditures] and cash flows;

▪future cash requirements, the availability, uses, [removed: sufficiency,] [added: sufficiency] and cost of capital resources, and sources of funding, including for future capital and R&D investments and for returns to stockholders, and credit ratings expectations;

▪future products, [removed: services,] [added: services] and technologies, and the expected goals, timeline, ramps, progress, availability, production, [removed: regulation,] [added: regulation] and benefits of such products, [removed: services,] [added: services] and technologies, including future process nodes and packaging technology, product roadmaps, schedules, future product architectures, expectations regarding process performance, per-watt [removed: parity,] [added: parity] and metrics, and expectations regarding product and process competitiveness;

▪projected [removed: manufacturing capacities, volumes, costs,] [added: costs] and yield trends;

▪internal and external manufacturing plans, including [added: future internal] manufacturing [added: volumes, manufacturing] expansion [removed: projects] [added: plans] and the financing [removed: therefor;][added: therefor, and external foundry usage;]

▪plans and goals related to Intel's foundry business, including with respect to anticipated [removed: governance,] customers, future manufacturing [removed: capacity,] [added: capacity] and service, [removed: technology,] [added: technology] and IP offerings;

▪expected timing and impact of acquisitions, [removed: divestitures,] [added: divestitures] and other significant [removed: transactions, including the sale of our NAND memory business;][added: transactions;]

▪expected [removed: timing,] completion and impacts of restructuring activities and cost-saving or efficiency initiatives;

[removed: ▪future social] [added: ▪social] and environmental performance goals, measures, [removed: strategies,] [added: strategies] and results;

▪our anticipated growth, future market share, [added: customer demand] and trends in our businesses and operations;

[removed: ▪future technology] [added: ▪technology] trends and developments, [removed: such as] [added: including with respect to] AI;

[removed: ▪future macro] [added: ▪macro] environmental and economic conditions;

Our Form 10-K includes Adjusted Free Cash Flow, a non-GAAP financial measure we use to evaluate the cash flow trends of our business.

See "Liquidity and Capital Resources" within MD&A for a description of this measure, including why management uses it and why we believe it provides investors with useful supplemental information.

| | | | | | | Page | | |

| Forward-Looking Statements | | | | | | 1 | | |

| Overview | | | | | | [3](#i0ab1c04f4cd944ffa1b64a7738970255_28) | | |

| Properties | | | | | | [32](#i0ab1c04f4cd944ffa1b64a7738970255_184) | | |

| Cybersecurity | | | | | | [54](#i0ab1c04f4cd944ffa1b64a7738970255_178) | | |

| Auditor's Reports | | | | | | [57](#i0ab1c04f4cd944ffa1b64a7738970255_208) | | |

| Consolidated Financial Statements | | | | | | [60](#i0ab1c04f4cd944ffa1b64a7738970255_217) | | |

| Key Terms | | | | | | [106](#i0ab1c04f4cd944ffa1b64a7738970255_454) | | |

| Controls and Procedures | | | | | | [109](#i0ab1c04f4cd944ffa1b64a7738970255_463) | | |

| Exhibits | | | | | | [110](#i0ab1c04f4cd944ffa1b64a7738970255_466) | | |

▪our business plans and strategy and anticipated benefits therefrom;

▪future production capacity and product supply;

▪anticipated trends and impacts related to industry component, substrate and foundry capacity utilization, shortages and constraints;

▪expectations regarding government funding, incentives, policies and priorities;

▪a potential pause or discontinuation of our pursuit of Intel 14A and other next generation leading-edge process technologies if we are unable to secure a significant external customer for Intel 14A;

▪alternative financing arrangements and pursuit of government grants;

▪the U.S. government's acquisition of significant equity interests in us;

▪changes in product demand and margins;

▪recently elevated geopolitical tensions, volatility and uncertainty with respect to international trade policies, including tariffs and export controls, impacting our business, the markets in which we compete and the world economy;

▪the need to attract, retain and motivate key talent;

We market and sell our products through a combination of direct sales through our global sales organization and indirect channels, including distributors, resellers, retailers and OEM partners.

As a U.S.-based integrated design manufacturer, or IDM, in addition to designing CPUs and other semiconductor products, we develop leading-edge semiconductor manufacturing process technologies, or nodes, and advanced packaging technologies and predominantly manufacture our semiconductor products at our manufacturing and assembly and test facilities, many of which are in the U.S. We are the only company undertaking research, design and development of leading-edge and next generation semiconductor manufacturing technologies and high-volume manufacturing of logic semiconductors utilizing leading-edge nodes in the U.S., making us a strategically important company from both a national economic and national security perspective.

In addition to manufacturing our own products, we offer third-party foundry services to external customers and aim to establish this business as a leading external foundry.

For more than 50 years, we have contributed to the advancement of computing technology that powers the digital world.

Building on our legacy of innovation, we are focused on transforming our business to meet the demands of a rapidly evolving technology landscape.

The pace of technological change, dynamic customer needs and intensifying competition continue to shape the semiconductor industry.

A secure, resilient and balanced semiconductor supply chain has become increasingly important to maintaining continuity of operations for global enterprises, governments and consumers, while meeting global demand in an uncertain and rapidly changing world.

We aim to build a new Intel for the future, undertaking an enterprise-wide transformation to strengthen execution, enhance innovation and better position our products and offerings in the complex, highly competitive and rapidly evolving technology landscape.

In 2025 and recent years, the semiconductor industry has experienced momentum driven by the following:

▪significantly increased compute demand, particularly for GPU systems, driven by generative AI workloads;

▪an expansion in the types of AI workloads as AI technologies are adopted across industries and applications;

▪a PC market driven by user refreshes that resulted from expanding AI capabilities, end-of-support for Windows 10 and aging devices from the COVID era; and

▪increased demand for secure and geographically diversified supply chains in a period of increased geopolitical tensions.

We expect these trends to continue in 2026 and future years, with continuing rapid adoption of AI technologies across an increasing number of industries and applications driving demand across a full spectrum of AI workloads, including generative AI, AI inference, agentic AI and physical AI, from traditional and AI data centers to network and enterprise environments and client and edge.

We believe AI represents a generational shift in computing requiring a range of compute silicon, including GPUs, ASICs, CPUs and xPUs.

Our multi-year strategy is designed to enable us to participate in the expanding market and increase in compute demand through our products and our foundry capabilities, including wafer manufacturing and advanced packaging.

Our strategy is centered on four core priorities:

▪Transforming our culture to become an engineering-focused, customer-centric organization that prioritizes decisive actions, disciplined execution and strong financial management;

| | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | |

Our Form 10-K includes key metrics that we use to measure our business, some of which are non-GAAP measures.

See "Non-GAAP Financial Measures" within MD&A for an explanation of these measures and why management uses them and believes they provide investors with useful supplemental information.

| Our Capital | | | | | | [5](#i52fa34b6ba9248c7a0a794e31846504f_43) | | |

| Non-GAAP Financial Measures | | | | | | [30](#i52fa34b6ba9248c7a0a794e31846504f_15393162793225) | | |

| Sales and Marketing | | | | | | [45](#i52fa34b6ba9248c7a0a794e31846504f_196) | | |

| Cybersecurity | | | | | | [48](#i52fa34b6ba9248c7a0a794e31846504f_202) | | |

| Properties | | | | | | [49](#i52fa34b6ba9248c7a0a794e31846504f_208) | | |

| Auditor's Reports | | | | | | [54](#i52fa34b6ba9248c7a0a794e31846504f_232) | | |

| Key Terms | | | | | | [100](#i52fa34b6ba9248c7a0a794e31846504f_466) | | |

| Controls and Procedures | | | | | | [102](#i52fa34b6ba9248c7a0a794e31846504f_475) | | |

| Exhibits | | | | | | [103](#i52fa34b6ba9248c7a0a794e31846504f_478) | | |

▪our business plans, strategy and leadership and anticipated benefits therefrom, including with respect to our foundry strategy, Smart Capital strategy, partnerships with Apollo and Brookfield, AI strategy, organizational structure, and management, including our search for a new CEO;

▪expectations regarding CHIPS Act funding and other governmental awards or potential future governmental incentives;

▪implementing new business strategies and investing in new businesses and technologies;

▪our ability to time and scale our capital investments appropriately and successfully secure favorable alternative financing arrangements and government grants;

▪changes in demand for our products and the margins we are able to make on them;

▪the ongoing need to attract, retain, and motivate key talent, including engineering and management talent, as we have undertaken multiple significant headcount reductions and had significant management changes in the last few years, including our CEO;

▪our having ceased to return capital to stockholders;

▪our initiatives and new legal requirements with respect to corporate responsibility matters; and

| Fundamentals of Our Business | | | | | |

We market and sell our semiconductor products directly through our global sales and marketing organizations and indirectly through channel partners.

We also develop semiconductor fabrication process and packaging technologies and manufacture many of our semiconductor product offerings at our geographically diverse network of fabrication and assembly and test facilities.

We are also seeking to expand as a third-party foundry for external customers.

Technology permeates every aspect of our lives and is increasingly central to every aspect of human existence.

As we look ahead to the next decade, we expect to see continued demand for processing power.

Semiconductors are the underlying technology powering this digital expansion, and we are strategically positioning ourselves to create a resilient global semiconductor supply chain by investing in geographically balanced manufacturing capacity.

The demand for compute is being accelerated by five superpowers: ubiquitous compute, pervasive connectivity, cloud-to-edge infrastructure, AI, and sensing.

Together, these superpowers combine to amplify and reinforce each other, and increase the world's need for computing by packing even more processing capability onto ever-smaller microchips.

We harness these superpowers for our customers' growth and our own.

We are uniquely positioned with the depth and breadth of our silicon, platforms, software, and packaging and process technology with at-scale manufacturing.

With these strengths and the tailwinds of the superpowers driving digital disruption, our strategy to win is focused on four key themes: product competitiveness, open platforms, manufacturing at scale, and our people.

| | | |

| --- | --- | --- |

| Product Competitiveness | | |

Lead and democratize compute with Intel x86 and xPU.

Our product offerings provide end-to-end solutions, scaling from data center to network, PCs, edge computing, and the emerging fields of AI and autonomous driving, to serve an increasingly smart and connected world.

At our core is the x86 ecosystem, which has served as a foundation of modern computing for over four decades.

| Item 1C. | | | Cybersecurity | | | Page [removed: [48](#i52fa34b6ba9248c7a0a794e31846504f_202)] [added: [54](#i0ab1c04f4cd944ffa1b64a7738970255_178)] | | |

| Item 2. | | | Properties | | | Pages [removed: [8](#i52fa34b6ba9248c7a0a794e31846504f_52), [49](#i52fa34b6ba9248c7a0a794e31846504f_208)] [added: [11](#i0ab1c04f4cd944ffa1b64a7738970255_55), [32](#i0ab1c04f4cd944ffa1b64a7738970255_184)] | | |

| Item 3. | | | Legal Proceedings | | | Pages [102](#i0ab1c04f4cd944ffa1b64a7738970255_448)\-[105](#i0ab1c04f4cd944ffa1b64a7738970255_451) | | |

| Item 3. | | | Legal Proceedings | | | Pages [96](#i52fa34b6ba9248c7a0a794e31846504f_460)\-[99](#i52fa34b6ba9248c7a0a794e31846504f_463) | | |

| Item 5. | | | Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities | | | Pages [removed: [6](#i52fa34b6ba9248c7a0a794e31846504f_46), [49](#i52fa34b6ba9248c7a0a794e31846504f_211)\-[50](#i52fa34b6ba9248c7a0a794e31846504f_217)] [added: [53](#i0ab1c04f4cd944ffa1b64a7738970255_187)] | | |

| Item 9A. | | | Controls and Procedures | | | Page [removed: [102](#i52fa34b6ba9248c7a0a794e31846504f_475)] [added: [109](#i0ab1c04f4cd944ffa1b64a7738970255_463)] | | |

| | | | Disclosure pursuant to Section 13(r) of the Securities Exchange Act of 1934 | | | Page [removed: [52](#i52fa34b6ba9248c7a0a794e31846504f_226)] [added: [54](#i0ab1c04f4cd944ffa1b64a7738970255_202)] | | |

| Item 10. | | | Directors, Executive Officers, and Corporate Governance | | | Page [removed: [51](#i52fa34b6ba9248c7a0a794e31846504f_223)] [added: [52](#i0ab1c04f4cd944ffa1b64a7738970255_199)] (a) | | |

| Item 15. | | | Exhibits and Financial Statement Schedules | | | Pages [56](#i0ab1c04f4cd944ffa1b64a7738970255_205)\-[108](#i0ab1c04f4cd944ffa1b64a7738970255_457), [110](#i0ab1c04f4cd944ffa1b64a7738970255_466)\-[115](#i0ab1c04f4cd944ffa1b64a7738970255_475) | | |

| Item 15. | | | Exhibits and Financial Statement Schedules | | | Pages [53](#i52fa34b6ba9248c7a0a794e31846504f_229)\-[101](#i52fa34b6ba9248c7a0a794e31846504f_469), [103](#i52fa34b6ba9248c7a0a794e31846504f_478)\-[107](#i52fa34b6ba9248c7a0a794e31846504f_487) | | |

*(a) Incorporated by reference to the applicable section of the [removed: 2025] [added: 2026] Proxy Statement.*

| [removed: ] [added: ] | | | Supplemental Details | | | [removed: 108] [added: 116] | | |

| | | | [removed: By:] [added: /s/ LIP-BU TAN] | | | | | | [added: | | |] /s/ DAVID ZINSNER | | | [added: | | |]

| | | | [added: Lip-Bu Tan Chief Executive Officer and Director (Principal Executive Officer)] | | | | | | [removed: Interim Co-Chief Executive Officer,] [added: | | | David Zinsner] Executive Vice President and Chief Financial Officer [added: (Principal Financial Officer)] | | | [added: | | |]

| | | | [removed: Interim Co-Chief Executive Officer, Executive] [added: Corporate] Vice President [removed: | | | | | | | | | Interim Co-Chief Executive Officer] and Chief [removed: Executive Officer,] [added: Accounting Officer (Principal Accounting Officer)] | | |

| | | | [removed: (Co-Principal Executive Officer and Principal Financial Officer)] | | | | | | [removed: | | | (Co-Principal] [added: Chief] Executive [added: Officer and Director (Principal Executive] Officer) | | |

| | | | /s/ [removed: JAMES J. GOETZ] [added: DR. CRAIG H. BARRATT] | | | | | | | | | /s/ [removed: DR. ANDREA] [added: JAMES] J. [removed: GOLDSMITH] [added: GOETZ] | | |

| | | | [removed: James J. Goetz] [added: Dr. Craig H. Barratt] | | | | | | | | | [removed: Dr. Andrea] [added: James] J. [removed: Goldsmith] [added: Goetz] | | |

| | | | /s/ [removed: ALYSSA HENRY] [added: DR. ANDREA J. GOLDSMITH] | | | | | | | | | /s/ [removed: DR. OMAR ISHRAK] [added: ALYSSA HENRY] | | |

| | | | [removed: Alyssa Henry] [added: Dr. Andrea J. Goldsmith] | | | | | | | | | [removed: Dr. Omar Ishrak] [added: Alyssa Henry] | | |

| | | | [removed: Interim Executive] Chair of the Board and Director | | | | | | | | | | | |

| [removed: ] [added: ] | | | Supplemental Details | | | [removed: 109] [added: 117] | | |

| Signatures | | | | | | Page [117](#i0ab1c04f4cd944ffa1b64a7738970255_481) | | |

| | | | By: | | | | | | /s/ LIP-BU TAN | | |

| | | | | | | | | | Lip-Bu Tan | | |

| | | | | | | | | | January 22, 2026 | | |

| | | | | | | | | | | | | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | | | | | | | | | | | | | |

| | | | January 22, 2026 | | | | | | | | | January 22, 2026 | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | | | | | | | | | | | | | | | |

| | | | January 22, 2026 | | |

| | | | | | |

| | | | January 22, 2026 | | | | | | | | | January 22, 2026 | | |

| | | | January 22, 2026 | | | | | | | | | January 22, 2026 | | |

| | | | January 22, 2026 | | | | | | | | | January 22, 2026 | | |

| | | | January 22, 2026 | | | | | | | | | January 22, 2026 | | |

| | | | January 22, 2026 | | | | | | | | | January 22, 2026 | | |

| | | | January 22, 2026 | | | | | | | | | | | |

| Signatures | | | | | | Page [109](#i52fa34b6ba9248c7a0a794e31846504f_493) | | |

| | | | | | | | | | David Zinsner | | |

| | | | | | | | | | January 31, 2025 | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | /s/ DAVID ZINSNER | | | | | | | | | /s/ MICHELLE JOHNSTON HOLTHAUS | | |

| | | | David Zinsner | | | | | | | | | Michelle Johnston Holthaus | | |

| | | | and Chief Financial Officer | | | | | | | | | Intel Products | | |

| | | | January 31, 2025 | | | | | | | | | January 31, 2025 | | |

| | | | Corporate Vice President and Chief Accounting Officer | | |

| | | | (Principal Accounting Officer) | | |

| | | | January 31, 2025 | | |

| | | | Director | | | | | | | | | Director | | |

| | | | January 31, 2025 | | | | | | | | | January 31, 2025 | | |

| | | | January 31, 2025 | | | | | | | | | January 31, 2025 | | |

| | | | /s/ DR. TSU-JAE KING LIU | | | | | | | | | /s/ DR. RISA LAVIZZO-MOUREY | | |

| | | | Dr. Tsu-Jae King Liu | | | | | | | | | Dr. Risa Lavizzo-Mourey | | |

| | | | January 31, 2025 | | | | | | | | | January 31, 2025 | | |

| | | | January 31, 2025 | | | | | | | | | January 31, 2025 | | |

| | | | January 31, 2025 | | | | | | | | | January 31, 2025 | | |

| | | | January 31, 2025 | | | | | | | | | January 31, 2025 | | |

| | | | January 31, 2025 | | | | | | | | | | | |